Study-level wavelet cluster analysis and data-driven signal models in pharmacological MRI

Journal of Neuroscience Methods

Volumn 159, Issue 2, 2007, Pages 346-360

  Schwarz, Adam J ^a   Whitcher, Brandon ^b   Gozzi, Alessandro ^a   Reese, Torsten ^a   Bifone, Angelo ^a  

^a GSK   (Italy)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Brain; Cluster analysis; Data driven; GLM; phMRI; Rat; Regressor; Signal model; Wavelet; WCA

Indexed keywords

APOMORPHINE; NICOTINE;

ALGORITHM; ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CLUSTER ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; IN VIVO STUDY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHARMACOLOGICAL STIMULATION; PRIORITY JOURNAL; RAT; SIGNAL DETECTION; SIMULATION; STATISTICAL MODEL;

ANIMALS; APOMORPHINE; ARTIFACTS; BRAIN; CLUSTER ANALYSIS; COMPUTER SIMULATION; DOPAMINE AGONISTS; MAGNETIC RESONANCE IMAGING; MODELS, BIOLOGICAL; NICOTINE; NICOTINIC AGONISTS; RATS; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 33845533374     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2006.07.017     Document Type: Article

References (62)

1. Beckmann C.F., DeLuca M., Devlin J.T., and Smith S.M. Investigations into resting-state connectivity using independent component analysis. Philos Trans R Soc Lond B: Biol Sci 360 (2005) 1001-1013
2. Beckmann C.F., and Smith S.M. Probabilistic independent component analysis for functional magnetic resonance imaging. IEEE Trans Med Imaging 23 (2004) 137-152
3. Beckmann C.F., and Smith S.M. Tensorial extensions of independent component analysis for multisubject FMRI analysis. NeuroImage 25 (2005) 294-311
4. Bloom A.S., Hoffmann R.G., Fuller S.A., Pankiewicz J., Harsch H.H., and Stein E.A. Determination of drug-induced changes in functional MRI signal using a pharmacokinetic model. Hum Brain Mapp 8 (1999) 235-244
5. Calhoun V.D., Adali T., McGinty V.B., Pekar J.J., Watson T.D., and Pearlson G.D. fMRI activation in a visual-perception task: network of areas detected using the general linear model and independent components analysis. NeuroImage 14 (2001) 1080-1088
6. Calhoun V.D., Adali T., Pearlson G.D., and Pekar J.J. A method for making group inferences from functional MRI data using independent component analysis. Hum Brain Mapp 14 (2001) 140-151
7. Calhoun V.D., Adali T., Pekar J.J., and Pearlson G.D. Latency (in)sensitive ICA. Group independent component analysis of fMRI data in the temporal frequency domain. NeuroImage 20 (2003) 1661-1669
8. Calhoun V.D., AdalI F.T., and Pekar J.J. A method for comparing group fMRI data using independent component analysis: application to visual, motor and visuomotor tasks. Magn Reson Imaging 22 (2004) 1181-1191
9. Chen Y.I., Brownell A.-L., Galpern W., Isacson O., Bogdanov M., Beal M.F., et al. Detection of dopaminergic cell loss and neural transplantation using pharmacological MRI, PET and behavioural assessment. NeuroReport 10 (1999) 2881-2886
10. Chen Y.I., Choi J.K., Andersen S.L., Rosen B.R., and Jenkins B.G. Mapping dopamine D2/D3 receptor function using pharmacological magnetic resonance imaging. Psychopharmacology (Berl) 180 (2005) 705-715
11. Chen Y.I., Galpern W.R., Brownell A.L., Matthews R.T., Bogdanov M., Isacson O., et al. Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data. Magn Reson Med 38 (1997) 389-398
12. Chen Y.I., Choi J.K., and Jenkins B.G. Mapping interactions between dopamine and adenosine A2a receptors using pharmacologic MRI. Synapse 55 (2005) 80-88
13. Choi J.K., Chen Y.I., Hamel E., and Jenkins B.G. Brain hemodynamic changes mediated by dopamine receptors: role of the cerebral microvasculature in dopamine-mediated neurovascular coupling. NeuroImage 30 (2006) 700-712
14. Dimitriadou E., Barth M., Windischberger C., Hornik K., and Moser E. A quantitative comparison of functional MRI cluster analysis. Artif Intell Med 31 (2004) 57-71
15. Dixon A.L., Prior M., Morris P.M., Shah Y.B., Joseph M.H., and Young A.M.J. Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRI. Neuropharmacology 48 (2005) 236-245
16. Friston K.J. Statistical parametric mapping and other analyses of functional imaging data. In: Toga A.W., and Mazziotta J.C. (Eds). Brain mapping: the methods (1996), Academic Press, San Diego 363-386
17. Friston K.J., Fletcher P., Josephs O., Holmes A., Rugg M.D., and Turner R. Event-related fMRI: characterizing differential responses. NeuroImage 7 (1998) 30-40
18. Goutte C., Toft P., Rostrup E., Nielsen F.A., and Hansen L.K. On clustering fMRI time series. NeuroImage 9 (1999) 298-310
19. Gozzi A., Ceolin L., Schwarz A.J., Reese T., Bertani S., and Bifone A. A multimodality investigation of cerebral haemodynamics and autoregulation in phMRI. Proceedings of the 14th ISMRM scientific meeting. Seattle, USA (2006) 2138
20. Gozzi A., Schwarz A.J., Reese T., Bertani S., Crestan V., and Bifone A. Region-specific effects of nicotine on brain activity: a pharmacological MRI study in the drug-naïve rat. Neuropsychopharmacology 31 (2006) 1690-1703
21. Gozzi A., Schwarz A.J., Reese T., Crestan V., Bertani S., Turrini G., et al. Functional magnetic resonance mapping of intracerebroventricular infusion of a neuroactive peptide in the anaesthetised rat. J Neurosci Methods 142 (2005) 115-124
22. Honey G., and Bullmore E. Human pharmacological MRI. Trends Pharmacol Sci 25 (2004) 366-374
23. Hopfinger J.B., Buchel C., Holmes A.P., and Friston K.J. A study of analysis parameters that influence the sensitivity of event-related fMRI analyses. NeuroImage 11 (2000) 326-333
24. Ireland M.D., Lowe A.S., Reavill C., James M.F., Leslie R.A., and Williams S.C.R. Mapping the effects of the selective dopamine D2/D3 receptor agonist quinelorane using pharmacological magnetic resonance imaging. Neuroscience 133 (2005) 315-326
25. Jenkins B.G., Chen Y.I., and Mandeville J.B. Pharmacological magnetic resonance imaging (phMRI). In: van Bruggen N., and Roberts T. (Eds). Biomedical imaging in experimental neuroscience (2003), CRC Press, New York 155-209
26. Jenkinson M., and Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal 5 (2001) 143-156
27. Jolliffe I.T. Principal component analysis (2002), Springer-Verlag, New York
28. Jones N., O'neill M.J., Tricklebank M., Libri V., and Williams S.C. Examining the neural targets of the AMPA receptor potentiator LY404187 in the rat brain using pharmacological magnetic resonance imaging. Psychopharmacology (Berl) 180 (2005) 743-751
29. Kalisch R., Salome N., Platzer S., Wigger A., Czisch M., Sommer W., et al. High trait anxiety and hyporeactivity to stress of the dorsomedial prefrontal cortex: a combined phMRI and Fos study in rats. NeuroImage 23 (2004) 382-391
30. Leslie R.A., and James M.F. Pharmacological magnetic resonance imaging: a new application for functional MRI. Trends Pharmacol Sci 21 (2000) 314-318
31. Littlewood C.L., Jones N., O'neill M.J., Mitchell S.N., Tricklebank M., and Williams S.C. Mapping the central effects of ketamine in the rat using pharmacological MRI. Psychopharmacology (Berl) 186 (2006) 64-81
32. Lowe A.S., Williams S.C.R., Symms M.R., Stolerman I.P., and Shoaib M. Functional magnetic resonance neuroimaging of drug dependence: anloxone-precipitated morphine withdrawal. NeuroImage 17 (2002) 902-910
33. Luo F., Wu G., Li Z., and Li S.J. Characterization of effects of mean arterial blood pressure induced by cocaine and cocaine methiodide on BOLD signals in rat brain. Magn Reson Med 49 (2003) 264-270
34. Luo F., Xi Z.X., Wu G., Liu C., Gardner E.L., and Li S.J. Attenuation of brain response to heroin correlates with the reinstatement of heroin-seeking in rats by fMRI. NeuroImage 22 (2004) 1328-1335
35. Mandeville J.B., Marota J.J.A., Kosofsky B.E., Keltner J.R., Weissleder R., Rosen B., et al. Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation. Magn Reson Med 39 (1998) 615-624
36. Marota J.J.A., Mandeville J.B., Weisskoff R., Moskowitz M.A., Rosen B., and Kosofsky B.E. Cocaine activation discriminates dopaminergic projections by temporal response: an fMRI study in rat. NeuroImage 11 (2000) 13-23
37. McKeown M.J., Makeig S., Brown G.G., Jung T.P., Kindermann S.S., Bell A.J., et al. Analysis of fMRI data by blind separation into independent spatial components. Hum Brain Mapp 6 (1998) 160-188
38. McKie S., Del Ben C., Elliott R., Williams S., del Vai N., Anderson I., et al. Neuronal effects of acute citalopram detected by pharmacoMRI. Psychopharmacology (Berl) 180 (2005) 680-686
39. Percival D.B., and Walden A.T. Wavelet methods for time series analysis (2000), Cambridge University Press, Cambridge
40. Reese T., Bjelke B., Porszasz R., Baumann D., Bochelen D., Sauter A., et al. Regional brain activation by bicuculline visualized by functional magnetic resonance imaging. Time-resolved assessment of bicuculline-induced changes in local cerebral blood volume using an intravascular contrast agent. NMR Biomed 13 (2000) 43-49
41. Risterucci C., Jeanneau K., Schoppenthau S., Bielser T., Kunnecke B., von Kienlin M., et al. Functional magnetic resonance imaging reveals similar brain activity changes in two different animal models of schizophrenia. Psychopharmacology (Berl) 180 (2005) 724-734
42. Schmidt K.F., Febo M., Shen Q., Luo F., Sicard K.M., Ferris C.F., et al. Hemodynamic and metabolic changes induced by cocaine in anesthetized rat observed with multimodal functional MRI. Psychopharmacology (Berl) 185 (2006) 479-486
43. Schmithorst V.J., and Holland S.K. Comparison of three methods for generating group statistical inferences from independent component analysis of functional magnetic resonance imaging data. J Magn Reson Imaging 19 (2004) 365-368
44. Schwarz A., Gozzi A., Reese T., Bertani S., Crestan V., Hagan J., et al. Selective dopamine D(3) receptor antagonist SB-277011-A potentiates phMRI response to acute amphetamine challenge in the rat brain. Synapse 54 (2004) 1-10
45. Schwarz A., Whitcher B., Reese T., Gozzi A., and Bifone A. Group-level data-driven phMRI analysis. Proceedings of the 13th ISMRM scientific meeting. Kyoto, Japan (2005) 157
46. Schwarz A.J., Danckaert A., Reese T., Gozzi A., Paxinos G., Watson C., et al. A stereotaxic MRI template set for the rat brain with tissue class distribution maps and co-registered anatomical atlas: application to pharmacological MRI. NeuroImage 32 (2006) 538-550
47. Schwarz A.J., Reese T., Gozzi A., and Bifone A. Functional MRI using intravascular contrast agents: detrending of the relative cerebrovascular (rCBV) time course. Magn Reson Imaging 21 (2003) 1191-1200
48. Schwarz A.J., Zocchi A., Reese T., Gozzi A., Garzotti M., Varnier G., et al. Concurrent pharmacological MRI and in situ microdialysis of cocaine reveal a complex relationship between the central hemodynamic response and local dopamine concentration. NeuroImage 23 (2004) 296-304
49. Shah Y.B., Prior M.J., Dixon A.L., Morris P.G., and Marsden C.A. Detection of cannabinoid agonist evoked increase in BOLD contrast in rats using functional magnetic resonance imaging. Neuropharmacology 46 (2004) 379-387
50. Shoaib M., Lowe A.S., and Williams S.C.R. Imaging localised dynamic changes in the nucleus accumbens following nicotine withdrawal in rats. NeuroImage 22 (2004) 847-854
51. Skoubis P.D., Hradil V., Chin C.L., Luo Y., Fox G.B., and McGaraughty S. Mapping brain activity following administration of a nicotinic acetylcholine receptor agonist, ABT-594, using functional magnetic resonance imaging in awake rats. Neuroscience 137 (2006) 583-591
52. Smith S.M., Jenkinson M., Woolrich M.W., Beckmann C.F., Behrens T.E., Johansen-Berg H., et al. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 23 Suppl. 1 (2004) S208-S219
53. Sommer F.T., and Wichert A. Exploratory analysis and data modeling in functional neuroimaging (2003), MIT Press, Cambridge, MA, USA
54. Stark J.A., Davies K.E., Williams S.R., and Luckman S.M. Functional magnetic resonance imaging and c-Fos mapping in rats following an anorectic dose of m-chlorophenylpiperazine. NeuroImage 31 3 (2006) 1228-1237
55. Stein E.A., Pankiewicz J., Harsch H.H., Cho J.-K., Fuller S.A., Hoffmann R.G., et al. Nicotine-induced limbic cortical activation in the human brain: a functional MRI study. Am J Psychiatr 155 (1998) 1009-1015
56. Thongsaard W., Marsden C.A., Morris P., Prior M., and Shah Y.B. Effect of Thunbergia laurifolia, a Thai natural product used to treat drug addiction, on cerebral activity detected by functional magnetic resonance imaging in the rat. Psychopharmacology (Berl) 180 (2005) 752-760
57. Whitcher B., Schwarz A.J., Barjat H., Smart S.C., Grundy R.I., and James M.F. Wavelet-based cluster analysis: data-driven grouping of voxel time courses with application to perfusion-weighted and pharmacological MRI of the rat brain. NeuroImage 24 (2005) 281-295
58. Windischberger C., Barth M., Lamm C., Schroeder L., Bauer H., Gur R.C., et al. Fuzzy cluster analysis of high-field functional MRI data. Artif Intell Med 29 (2003) 203-223
59. Xi Z.-X., Wu G., Stein E.A., and Li S.-J. GABAergic mechanisms of heroin-induced brain activation assessed with functional MRI. Magn Reson Med 48 (2002) 838-843
60. Xi Z.X., Wu G., Stein E.A., and Li S.J. Opiate tolerance by heroin self-administration: an fMRI study in rat. Magn Reson Med 52 (2004) 108-114
61. Xu H., Li S.-J., Bodurka J., Zhao X., Xi Z.-X., and Stein E.A. Heroin-induced neuronal activation in rat brain assessed by functional MRI. NeuroReport 11 (2000) 1085-1092
62. Zaharchuk G., Mandeville J.B., Bogdanov Jr. A.A., Weissleder R., Rosen B.R., and Marota J.J. Cerebrovascular dynamics of autoregulation and hypoperfusion. An MRI study of CBF and changes in total and microvascular cerebral blood volume during hemorrhagic hypotension. Stroke 30 (1999) 2197-2204